Diagnostic Robotics

Executive Summary

Diagnostic Robotics is an Israeli AI-driven medtech company that has developed Maxine, a virtual assistant designed to automate repetitive administrative tasks in healthcare settings. By leveraging large-scale machine learning and natural language processing, Maxine handles patient outreach, scheduling, documentation, and care-gap closure, allowing healthcare providers to increase efficiency, reduce costs, and improve patient satisfaction. The platform integrates seamlessly with existing EHR and practice-management systems, positioning the company as a scalable solution for value-based care. Founded in 2020 and headquartered in Tel Aviv, the company has grown to 200-500 employees and is at the platform stage, indicating a mature product ready for broad adoption. Maxine addresses the critical pain point of administrative burden in healthcare, which is a major driver of burnout and inefficiency. With the shift toward value-based care, providers are increasingly seeking technologies that can automate workflows and close care gaps. Diagnostic Robotics' strong focus on NLP and integration capabilities gives it a competitive edge. The company is well-positioned to expand in the US market, where demand for AI-powered administrative assistants is growing. Upcoming catalysts include potential strategic partnerships with large health systems and new feature launches that could accelerate adoption and attract additional funding.

Upcoming Catalysts (preview)

• Q3 2026Strategic Partnership with Major US Health System60% success
• Q1 2027Expansion of Maxine's Clinical Documentation Capabilities70% success
• Q2 2026Series B/C Funding Round80% success